Janux Therapeutics Inc

NASDAQ JANX

Data sourced from iex and EODHD
Download Data

Janux Therapeutics Inc Income Statement 2020 - 2024

This table shows the Income Statement for Janux Therapeutics Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 1 2 3 1 2 3 2 2 2 2 1 0 0 0 0 0 0
Cost of Revenue
M 1 1 1 0 0 0 20 20 15 - 12 7 - - - - -
Gross Profit
M 1 2 2 1 2 2 2 2 2 2 1 0 0 - - - -
Operating Expenses
M 21 18 18 21 22 21 20 20 15 15 12 7 3 - - - -
Selling, General, and Administrative Expenses (SG&A)
M 7 6 6 7 6 6 6 6 5 4 4 2 1 1 0 0 0
Research and Development (R&D) Expenses
M 14 12 12 15 16 15 14 14 10 11 8 5 2 1 1 1 1
Other Operating Expenses
M -1 -1 -1 0 0 0 0 0 0 0 0 0 0 - - - -
Costs and Expenses
M 20 18 18 21 22 21 0 0 0 - 0 0 - - - - -
Operating Income
M -20 -16 -16 -21 -20 -18 -18 -17 -14 -13 -11 -6 -2 -2 -1 -1 -1
Interest Expense
M - 3 - - -3 2 1 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 5 4 4 3 3 2 1 0 0 0 0 0 - 0 - -1 0
EBT
M -15 -12 -12 -18 -17 -16 -17 -17 -13 -13 -11 -6 -2 -2 -1 -2 -1
Income Tax Provision
M - 1 -1 - 0 -5 -3 0 0 0 0 0 - - - -1 0
Income after Tax
M - -13 -11 - -17 -11 -14 -17 -13 -13 -11 -6 - - - -1 -1
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Net Income
M - - - -18 -17 -16 -17 -17 -13 -13 -11 -6 -2 - -1 -2 -1
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 49,049,741.00 46,683,613.00 45,708,649.00 41,836,238.00 41,763,971.00 41,584,195.00 41,526,524.00 41,448,743.00 41,315,482.00 41,208,323.00 41,134,102.00 10,033,328.00 39,901,510.00 12,472,673.00 12,472,673.00 12,472,673.00 12,472,673.00
EBITDA
M -20 -16 -16 -20 -20 -18 -18 -17 -13 -13 -11 -6 -2 -2 -1 -2 -1
Depreciation and Amortization
M 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -20 -16 -16 -21 -21 -19 -18 -17 -14 -14 -11 -6 -2 -2 -1 -2 -1
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - -8.11 4.32 - 2.59 29.91 15.88 2.21 1.97 0.55 -1.27 -0.74 - - - 46.18 27.81
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% 57.51 78.42 80.14 55.44 77.88 85.83 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - -
Operating Income Margin
% -1,610.30 -655.71 -628.25 -1,962.91 -990.28 -642.04 -994.04 -729.85 -852.23 -834.78 -940.72 -1,297.10 -601.05 - - - -
Net Income Margin
% - - - -1,656.39 -852.49 -564.67 -920.90 -714.08 -843.93 -830.20 -928.90 -1,287.55 -601.05 - - - -
EBITDA Ratio
% -1,567.81 -634.13 -628.25 -1,918.35 -990.28 -642.04 -980.31 -725.29 -847.14 -834.78 -926.57 -1,284.85 -598.68 - - - -
EBIT Ratio
% -1,610.30 -655.71 -648.11 -1,962.91 -1,012.40 -656.20 -994.04 -729.85 -852.23 -838.74 -928.90 -1,287.55 -601.05 - - - -
EBT Ratio
% -1,178.91 -477.77 -459.59 -1,656.39 -852.49 -564.67 -920.90 -714.08 -843.93 -830.20 -928.90 -1,287.55 -601.05 - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email